Privacy

Privacy Statement

Galderma Laboratories, L.P. Internet Privacy Policy
Galderma respects the privacy of every individual visiting our websites. Galderma's Privacy Policy, outlining the information Galderma collects and how Galderma uses such information is as follows:

Personally Identifiable Information
Galderma collects personally identifiable information (such as name, address, telephone/fax number and email address) only when voluntarily provided by a visitor to our websites. Galderma does not sell, rent or otherwise make available any personally identifiable information submitted by visitors to our website to any third parties. This information will not be used for any direct marketing or unsolicited follow-up unless we have previously informed you of this possible use and you have given us your express permission when submitting it. Galderma may use this information for such purposes as:

  • Sending you paper publications or other correspondence
  • Sending you email press releases or notification
  • Delivering goods or prizes

Only authorized Galderma staff or our agents (who have agreed to keep information secure) have access to personally identifiable information.

Galderma does make use of non-personally identifiable statistical information collected from users (browser type, geographical location, age, gender) for optimization of its sites as part of its continual internal review process and in a general way to learn more about its clients. This information will not be disclosed to third parties by Galderma. This data will only be used for the stated purpose and will not be used for any unsolicited communication unless you give us permission.

Log Files
We use IP addresses to analyze trends, administer the site, track users' movements, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Cookies
Galderma does use tracking technology (known as 'cookies'), which deposits certain bits of information on your hard drive. Cookies allow us to track and target your interests to tailor our sites to suit your needs better.

Children
Children and young people under 16 are requested to get permission from their parent or guardian before they submit personal data to Galderma websites.

Links
Links from this site may take you to other sites. Please be aware that we are not responsible for the privacy practices of such other sites. We advise you to check their privacy policies yourself before submitting any personally identifiable information.

Changes
This policy may be modified from time to time, and changes will be communicated promptly on this page. Please contact us for more information on this policy.
Webmaster
Galderma Laboratories, L.P.
webmaster@galderma.com

Important Safety Information
Indication: EPIDUO® Gel is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (≥1%) in patients treated with EPIDUO® Gel were dry skin, contact dermatitis, application site burning, application site irritation and skin irritation. Warnings/Precautions: Patients taking EPIDUO® Gel should avoid exposure to sunlight and sunlamps and wear sunscreen when sun exposure cannot be avoided. Erythema, scaling, dryness, stinging/ burning, irritant and allergic contact dermatitis may occur with use of EPIDUO® Gel and may necessitate discontinuation.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‐800‐FDA‐1088.

*This savings is not valid for prescriptions paid for in part or full by any federal or state program, including Medicaid, Medicare, or Medigap ("Government Program"). Void where prohibited by law, taxed, or restricted. THIS OFFER IS AVAILABLE FOR A LIMITED TIME ONLY AND GALDERMA LABORATORIES RESERVES THE RIGHT TO RESCIND, REVOKE, AMEND, OR TERMINATE THIS OFFER AT ANY TIME WITHOUT NOTICE. Insured patients could pay no more than $25* for their first Epiduo® Gel prescription, $15 for their first refill and $10 for additional refills (for one tube or pump, after primary insurance and the Epiduo Gel Savings Card). Payment will depend on actual insurance coverage.

©2013 Galderma Laboratories, L.P. United States, All Rights Reserved. All trademarks are the property of their respective owners. This site intended for U.S. audiences only. Information in this website is not intended as medical advice. Talk to your doctor about medical concerns.

Important Safety Information

Indication: EPIDUO® Gel is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (≥1%) in patients treated with EPIDUO® Gel were dry skin, contact dermatitis, application site burning, application site irritation and skin irritation. Warnings/Precautions: Patients taking EPIDUO® Gel should avoid exposure to sunlight and sunlamps and wear sunscreen when sun exposure cannot be avoided. Erythema, scaling, dryness, stinging/ burning, irritant and allergic contact dermatitis may occur with use of EPIDUO® Gel and may necessitate discontinuation.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Share the news

Send me a copy of this email

See Privacy Policy >